If a Ras protein is inappropriately activated, as in the case of KRAS mutation in mucinous ovarian carcinoma, it can result in proteins that promote uncontrolled cell growth and proliferation. This evidence concerns the gene KRAS and ovarian mucinous adenocarcinoma.